Adam J. de Smith

6.9k citations
108 papers · 3.3k · 1 hit paper · h-index 29

Impact in

    • Phytochemicals and Antioxidant Activities
  • Genetics top 2%
    • Genomic variations and chromosomal abnormalities
    • Genetic Syndromes and Imprinting
    • Genomics and Rare Diseases

Papers in

Adam J. de Smith

102 papers receiving 3.3k citations

Adam J. de Smith's Hit Papers

Phase I clinical trial of the flavonoid quercetin: pharmacokinetics and evidence for in vivo tyrosine kinase inhibition. 1996 · 538 citations
5380+10+20Years since publication100200300400500

Peers

Adam J. de Smith
Comparison fields: 5 of 138
  • Biochemistry 190
  • Genetics 796
  • Biological Psychiatry 60
  • Molecular Biology 1.3k
  • Pediatrics, Perinatology and Child Health 314
Replace Mary J. Malloy with:
Mary J. Malloy United States
Jordi Muntané Spain
Renee Leboeuf United States
M. Julia Brosnan United Kingdom
Michelle S. Johnson United States
Akira Uruno Japan
Mats Rudling Sweden
Lawrence W. Castellani United States
Yutaka Nishigaki Japan
Todd G. Kirchgessner United States
Adam J. de Smith relative to Mary J. Malloy United States Mary J. Malloy's profile →
Citations per field
00.5×1.5×2.2×
Mary J. Malloy · 1×
Citations per year

Countries citing papers authored by Adam J. de Smith

Since Specialization
Citations

This map shows the geographic impact of Adam J. de Smith's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Adam J. de Smith with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Adam J. de Smith more than expected).

Fields of papers citing papers by Adam J. de Smith

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Adam J. de Smith. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Adam J. de Smith. The network helps show where Adam J. de Smith may publish in the future.

Co-authors

The 25 scholars most cited alongside Adam J. de Smith, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Adam J. de Smith Line = papers co-authored together Adam J. de Smith links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 108 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Phase I clinical trial of the flavonoid quercetin: pharmacokinetics and evidence for in vivo tyrosine kinase inhibition.
Hit paper breakdown →
1996538
2 2007354
3 2009218
4 2007176
5 2011150
6 2014128
7 2015110
8 201285
9 201585
10 201674
11 201572
12 201871
13 201353
14 201652
15 200852
16 201651
17 201648
18 200844
19 201436
20 202236

About Adam J. de Smith

Adam J. de Smith is a scholar working on Molecular Biology, Public Health, Environmental and Occupational Health, Genetics, Pediatrics, Perinatology and Child Health and Physiology, having authored 108 papers that have together received 3.3k indexed citations. Recurring topics across this work include Acute Lymphoblastic Leukemia research (34 papers), Epigenetics and DNA Methylation (28 papers), Childhood Cancer Survivors' Quality of Life (18 papers), Genomic variations and chromosomal abnormalities (14 papers), Alzheimer's disease research and treatments (7 papers), RNA modifications and cancer (7 papers), Acute Myeloid Leukemia Research (6 papers) and Genomics and Rare Diseases (6 papers). The work is most often cited by research in Biochemistry (190 citations), Genetics (796 citations), Biological Psychiatry (60 citations), Molecular Biology (1.3k citations) and Pediatrics, Perinatology and Child Health (314 citations). Adam J. de Smith has collaborated with scholars based in United States, United Kingdom and France. Frequent co-authors include Alexandra I. F. Blakemore, Joseph L. Wiemels, Philippe Froguel, J Baker, D. Fyfe, David A. Anderson, D. Ferry, Rachel Kerr, Catherine Metayer and Kyle M. Walsh. Their work appears in journals such as Blood, Human Molecular Genetics, Cancer Epidemiology Biomarkers & Prevention, Leukemia and Blood Advances.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact